Nektar Therapeutics (NKTR) Misses Q1 Views on Top and Bottom
Tweet
Share
E-mailGet Alerts NKTR Hot Sheet
Price: $73.02 -3.82%
Financial Fact:
Research and development: 51.95M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development: 51.95M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Nektar Therapeutics (NASDAQ: NKTR) reported Q1 loss of $0.33, $0.06 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $11.3 million versus the consensus estimate of $17.2 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nektar Therapeutics (NKTR) Tops Q2 EPS by 77c
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
